Biotech FibroGen soars more than 50% on positive lung disease treatment study
August 8, 2017 | Uncategorized
The biotech company's drug pamrevlumab successfully completed a mid-stage Food and Drug Administration test.
The biotech company's drug pamrevlumab successfully completed a mid-stage Food and Drug Administration test.
